Bronchiectasis (Respiratory) - Drugs In Development, 2021

Publisher Name :
Date: 30-Aug-2021
No. of pages: 123
Inquire Before Buying

Bronchiectasis (Respiratory) - Drugs In Development, 2021

Summary

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bronchiectasis - Drugs In Development, 2021, provides an overview of the Bronchiectasis (Respiratory) pipeline landscape.Bronchiectasis is a chronic condition where the walls of the bronchial tubes are permanently damaged. These damage allow bacteria and mucus to build up in lungs. Bronchiectasis is divided into two categories cystic fibrosis (CF) bronchiectasis and non-CF bronchiectasis. Symptoms include chronic coughing, shortness of breath, chest pain, fatigue, weight loss and fever. Causes of bronchiectasis include inhaling foreign object, cystic fibrosis, GERD and weakness in immune system. Treatment includes antibiotics to fight infection, bronchodilators, expectorants and mucolytic agents.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Bronchiectasis - Drugs In Development, 2021, provides comprehensive information on the therapeutics under development for Bronchiectasis (Respiratory), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.The Bronchiectasis (Respiratory) pipeline guide also reviews of key players involved in therapeutic development for Bronchiectasis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase II, Phase I, Preclinical and Discovery stages are 3, 4, 6, 9 and 4 respectively. Similarly, the Universities portfolio in Phase II and Preclinical stages comprises 1 and 1 molecules, respectively.

Bronchiectasis (Respiratory) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

- The pipeline guide provides a snapshot of the global therapeutic landscape of Bronchiectasis (Respiratory).

- The pipeline guide reviews pipeline therapeutics for Bronchiectasis (Respiratory) by companies and universities/research institutes based on information derived from company and industry-specific sources.

- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

- The pipeline guide reviews key companies involved in Bronchiectasis (Respiratory) therapeutics and enlists all their major and minor projects.

- The pipeline guide evaluates Bronchiectasis (Respiratory) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

- The pipeline guide reviews latest news related to pipeline therapeutics for Bronchiectasis (Respiratory)

Reasons to Buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Bronchiectasis (Respiratory).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it's most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Bronchiectasis (Respiratory) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Bronchiectasis (Respiratory) - Drugs In Development, 2021

Table of Contents
Introduction
Bronchiectasis - Overview
Bronchiectasis - Therapeutics Development
Bronchiectasis - Therapeutics Assessment
Bronchiectasis - Companies Involved in Therapeutics Development
Bronchiectasis - Drug Profiles
Bronchiectasis - Dormant Projects
Bronchiectasis - Discontinued Products
Bronchiectasis - Product Development Milestonesh
Appendix

List of Tables
Number of Products under Development for Bronchiectasis, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Products under Development by Companies, 2021
Products under Development by Universities/Institutes, 2021
Number of Products by Stage and Target, 2021
Number of Products by Stage and Mechanism of Action, 2021
Number of Products by Stage and Route of Administration, 2021
Number of Products by Stage and Molecule Type, 2021
Bronchiectasis - Pipeline by Alaxia SAS, 2021
Bronchiectasis - Pipeline by Alitair Pharmaceuticals Inc, 2021
Bronchiectasis - Pipeline by Armata Pharmaceuticals, 2021
Bronchiectasis - Pipeline by Boehringer Ingelheim International GmbH, 2021
Bronchiectasis - Pipeline by Chiesi Farmaceutici SpA, 2021
Bronchiectasis - Pipeline by Cila Therapeutics, 2021
Bronchiectasis - Pipeline by CSL Ltd, 2021
Bronchiectasis - Pipeline by Destiny Pharma Plc, 2021
Bronchiectasis - Pipeline by Helperby Therapeutics Group Ltd, 2021
Bronchiectasis - Pipeline by Insmed Inc, 2021
Bronchiectasis - Pipeline by Kamada Pharmaceuticals, 2021
Bronchiectasis - Dormant Projects, 2021
Bronchiectasis - Discontinued Products, 2021

List of Figures
Number of Products under Development for Bronchiectasis, 2021
Number of Products under Development by Companies, 2021
Number of Products under Development by Universities/Institutes, 2021
Number of Products by Top 10 Targets, 2021
Number of Products by Stage and Top 10 Targets, 2021
Number of Products by Top 10 Mechanism of Actions, 2021
Number of Products by Stage and Top 10 Mechanism of Actions, 2021
Number of Products by Routes of Administration, 2021
Number of Products by Stage and Routes of Administration, 2021
Number of Products by Top 10 Molecule Types, 2021
Number of Products by Stage and Top 10 Molecule Types, 2021
  • Global Carbocisteine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    Published: 09-Nov-2021        Price: US 3480 Onwards        Pages: 90
    The Carbocisteine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to our latest research,......
  • Global Respiratory Partnering 2010-2021: Deal trends, players and financials
    Published: 01-Nov-2021        Price: US 3495 Onwards        Pages: 600
    Global Respiratory Partnering 2010 to 2021 provides the full collection of Respiratory disease deals signed between the world's pharmaceutical and biotechnology companies since 2010. Trends in Respiratory partnering deals Financial deal terms for headline, upfront and royalty by stage of development Respiratory partnering agreement structure Respiratory partnering contract documents Top Respiratory deals by value Most active Respiratory dealmakers......
  • China Ambroxol Market Report & Forecast 2021-2027
    Published: 18-Oct-2021        Price: US 3400 Onwards        Pages: 92
    China Ambroxol Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Ambroxol Market Segment Percentages, By Type, 2020 (%) - Normal type - Long-acting type China Ambroxol Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) China Ambroxol Market Segment Percentages, By Application, 2020 (%) - Acute Respiratory Diseases - Chronic Respiratory Diseases Competitor Analysis The report also prov......
  • Global and Japan Bovine Respiratory Disease Treatment Market Size, Status and Forecast 2021-2027
    Published: 05-Oct-2021        Price: US 3900 Onwards        Pages: 97
    Global Bovine Respiratory Disease Treatment Scope and Market Size Bovine Respiratory Disease Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Bovine Respiratory Disease Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the p......
  • United States Ambroxol Market Report & Forecast 2021-2027
    Published: 30-Sep-2021        Price: US 3400 Onwards        Pages: 94
    United States Ambroxol Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) United States Ambroxol Market Segment Percentages, By Type, 2020 (%) - Normal type - Long-acting type United States Ambroxol Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs) United States Ambroxol Market Segment Percentages, By Application, 2020 (%) - Acute Respiratory Diseases - Chronic Respiratory Diseases Competitor Anal......
  • Obstructive Sleep Apnea - Global Clinical Trials Review, H2, 2021
    Published: 21-Sep-2021        Price: US 2500 Onwards        Pages: 250
    Obstructive Sleep Apnea - Global Clinical Trials Review, H2, 2021 Summary GlobalData's clinical trial report, "Obstructive Sleep Apnea - Global Clinical Trials Review, H2, 2021" provides an overview of Obstructive Sleep Apnea Clinical trials scenario. This report provides top line data relating to the clinical trials on Obstructive Sleep Apnea . Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The rep......
  • Global and China Carbocisteine Market Insights, Forecast to 2027
    Published: 10-Sep-2021        Price: US 3900 Onwards        Pages: 139
    Carbocisteine (INN), also called carbocysteine (USAN), is a mucolytic that reduces the viscosity of sputum and so can be used to help relieve the symptoms of chronic obstructive pulmonary disorder (COPD) and bronchiectasis by allowing the sufferer to bring up sputum more easily. Carbocisteine should not be used with antitussives (cough suppressants) or medicines that dry up bronchial secretions. In this report, we study the Carbocisteine API. Global Carbocisteine key players include Moehs......
  • United States Carbocisteine Market Report & Forecast 2021-2027
    Published: 09-Sep-2021        Price: US 3400 Onwards        Pages: 91
    United States Carbocisteine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (MT) United States Carbocisteine Market Segment Percentages, By Type, 2020 (%) - 0.985 - Above 98.50% United States Carbocisteine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (MT) United States Carbocisteine Market Segment Percentages, By Application, 2020 (%) - Oral Solution - Tablet & Capsule - Others Competitor Analysis......
  • Cystic Fibrosis (CF) - Epidemiology Forecast to 2030
    Published: 31-Aug-2021        Price: US 3995 Onwards        Pages: 41
    Cystic Fibrosis (CF) - Epidemiology Forecast to 2030 Summary Cystic fibrosis (CF) is a progressive, inherited disorder that primarily affects the respiratory and digestive systems. In people with CF, mucus, sweat, and other fluids produced in these systems are sticky and thick, and may obstruct the passageways in the lungs and pancreas (Mayo Clinic, 2021). Mucus build-up and airway blockages in the lungs cause symptoms such as persistent cough, wheezing, inflamed nasal ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs